nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—Sulfaphenazole—Sulfasalazine—Crohn's disease	0.25	1	CrCrCtD
Celecoxib—osteoarthritis—Prednisone—Crohn's disease	0.247	1	CpDpCtD
Celecoxib—PTGS2—Crohn's disease	0.0882	0.529	CbGaD
Celecoxib—ALB—Crohn's disease	0.0785	0.471	CbGaD
Celecoxib—PTGS2—Balsalazide—Crohn's disease	0.0574	0.288	CbGbCtD
Celecoxib—ABCC4—Mercaptopurine—Crohn's disease	0.0535	0.268	CbGbCtD
Celecoxib—PTGS2—Mesalazine—Crohn's disease	0.0459	0.23	CbGbCtD
Celecoxib—PTGS2—Sulfasalazine—Crohn's disease	0.0257	0.129	CbGbCtD
Celecoxib—ALB—Prednisone—Crohn's disease	0.0129	0.0648	CbGbCtD
Celecoxib—CYP3A4—Prednisone—Crohn's disease	0.00405	0.0203	CbGbCtD
Celecoxib—ORM1—bile—Crohn's disease	0.00311	0.134	CbGeAlD
Celecoxib—CA9—gall bladder—Crohn's disease	0.00147	0.0635	CbGeAlD
Celecoxib—CA6—mouth—Crohn's disease	0.00144	0.0623	CbGeAlD
Celecoxib—MAPK14—mouth—Crohn's disease	0.00127	0.055	CbGeAlD
Celecoxib—PDPK1—lymphoid tissue—Crohn's disease	0.00107	0.0461	CbGeAlD
Celecoxib—PDPK1—digestive system—Crohn's disease	0.00105	0.0455	CbGeAlD
Celecoxib—ORM1—gall bladder—Crohn's disease	0.000863	0.0373	CbGeAlD
Celecoxib—ALB—gall bladder—Crohn's disease	0.000756	0.0327	CbGeAlD
Celecoxib—MAPK14—epithelium—Crohn's disease	0.000741	0.032	CbGeAlD
Celecoxib—MAPK14—smooth muscle tissue—Crohn's disease	0.000714	0.0309	CbGeAlD
Celecoxib—MAPK14—skin of body—Crohn's disease	0.000705	0.0305	CbGeAlD
Celecoxib—PDPK1—lymph node—Crohn's disease	0.000602	0.026	CbGeAlD
Celecoxib—CA9—digestive system—Crohn's disease	0.000578	0.025	CbGeAlD
Celecoxib—MAPK14—lymphoid tissue—Crohn's disease	0.000571	0.0247	CbGeAlD
Celecoxib—MAPK14—digestive system—Crohn's disease	0.000564	0.0244	CbGeAlD
Celecoxib—CA2—gall bladder—Crohn's disease	0.000558	0.0241	CbGeAlD
Celecoxib—CA2—mouth—Crohn's disease	0.000496	0.0214	CbGeAlD
Celecoxib—CA5B—mammalian vulva—Crohn's disease	0.000438	0.0189	CbGeAlD
Celecoxib—CA12—digestive system—Crohn's disease	0.000428	0.0185	CbGeAlD
Celecoxib—PTGS2—gall bladder—Crohn's disease	0.000412	0.0178	CbGeAlD
Celecoxib—PTGS2—mouth—Crohn's disease	0.000366	0.0158	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—Crohn's disease	0.000331	1	CrCbGaD
Celecoxib—MAPK14—lymph node—Crohn's disease	0.000322	0.0139	CbGeAlD
Celecoxib—CA2—epithelium—Crohn's disease	0.000289	0.0125	CbGeAlD
Celecoxib—ABCC4—digestive system—Crohn's disease	0.000288	0.0124	CbGeAlD
Celecoxib—CA2—smooth muscle tissue—Crohn's disease	0.000278	0.012	CbGeAlD
Celecoxib—CA2—skin of body—Crohn's disease	0.000275	0.0119	CbGeAlD
Celecoxib—CA4—digestive system—Crohn's disease	0.000265	0.0114	CbGeAlD
Celecoxib—CA2—mammalian vulva—Crohn's disease	0.00025	0.0108	CbGeAlD
Celecoxib—CA2—lymphoid tissue—Crohn's disease	0.000222	0.00961	CbGeAlD
Celecoxib—CA2—digestive system—Crohn's disease	0.00022	0.00949	CbGeAlD
Celecoxib—CA5B—lymph node—Crohn's disease	0.000219	0.00947	CbGeAlD
Celecoxib—PTGS2—epithelium—Crohn's disease	0.000213	0.00921	CbGeAlD
Celecoxib—PTGS2—smooth muscle tissue—Crohn's disease	0.000205	0.00887	CbGeAlD
Celecoxib—PTGS2—skin of body—Crohn's disease	0.000203	0.00876	CbGeAlD
Celecoxib—ORM1—lymph node—Crohn's disease	0.000194	0.00838	CbGeAlD
Celecoxib—CYP2C9—digestive system—Crohn's disease	0.000186	0.00803	CbGeAlD
Celecoxib—ALB—lymph node—Crohn's disease	0.00017	0.00735	CbGeAlD
Celecoxib—ABCC4—lymph node—Crohn's disease	0.000165	0.00711	CbGeAlD
Celecoxib—PTGS2—lymphoid tissue—Crohn's disease	0.000164	0.00709	CbGeAlD
Celecoxib—PTGS2—digestive system—Crohn's disease	0.000162	0.00701	CbGeAlD
Celecoxib—Glaucoma—Prednisone—Crohn's disease	0.000161	0.00241	CcSEcCtD
Celecoxib—Face oedema—Mesalazine—Crohn's disease	0.00016	0.0024	CcSEcCtD
Celecoxib—Arthralgia—Mercaptopurine—Crohn's disease	0.000157	0.00235	CcSEcCtD
Celecoxib—Fungal infection—Prednisone—Crohn's disease	0.000157	0.00235	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000156	0.00233	CcSEcCtD
Celecoxib—Blood creatinine increased—Mesalazine—Crohn's disease	0.000156	0.00233	CcSEcCtD
Celecoxib—Pancreatitis—Azathioprine—Crohn's disease	0.000155	0.00231	CcSEcCtD
Celecoxib—Liver function test abnormal—Mesalazine—Crohn's disease	0.000153	0.00229	CcSEcCtD
Celecoxib—Dry skin—Mesalazine—Crohn's disease	0.000152	0.00228	CcSEcCtD
Celecoxib—Abdominal pain upper—Mesalazine—Crohn's disease	0.000152	0.00227	CcSEcCtD
Celecoxib—CA4—lymph node—Crohn's disease	0.000151	0.00654	CbGeAlD
Celecoxib—Oedema—Mercaptopurine—Crohn's disease	0.00015	0.00225	CcSEcCtD
Celecoxib—Breast disorder—Mesalazine—Crohn's disease	0.00015	0.00225	CcSEcCtD
Celecoxib—Pancytopenia—Azathioprine—Crohn's disease	0.00015	0.00224	CcSEcCtD
Celecoxib—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00015	0.00224	CcSEcCtD
Celecoxib—Nasopharyngitis—Mesalazine—Crohn's disease	0.000149	0.00222	CcSEcCtD
Celecoxib—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000147	0.0022	CcSEcCtD
Celecoxib—Gastritis—Mesalazine—Crohn's disease	0.000147	0.0022	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000147	0.00219	CcSEcCtD
Celecoxib—Skin disorder—Mercaptopurine—Crohn's disease	0.000146	0.00219	CcSEcCtD
Celecoxib—Dysphagia—Mesalazine—Crohn's disease	0.000144	0.00215	CcSEcCtD
Celecoxib—Anorexia—Mercaptopurine—Crohn's disease	0.000143	0.00215	CcSEcCtD
Celecoxib—Eosinophilia—Mesalazine—Crohn's disease	0.000142	0.00213	CcSEcCtD
Celecoxib—CYP3A4—digestive system—Crohn's disease	0.000142	0.00612	CbGeAlD
Celecoxib—Pneumonia—Azathioprine—Crohn's disease	0.000141	0.00212	CcSEcCtD
Celecoxib—Bronchospasm—Mesalazine—Crohn's disease	0.000141	0.00211	CcSEcCtD
Celecoxib—Pancreatitis—Mesalazine—Crohn's disease	0.000141	0.00211	CcSEcCtD
Celecoxib—Infestation NOS—Azathioprine—Crohn's disease	0.000141	0.0021	CcSEcCtD
Celecoxib—Infestation—Azathioprine—Crohn's disease	0.000141	0.0021	CcSEcCtD
Celecoxib—Angina pectoris—Mesalazine—Crohn's disease	0.00014	0.00209	CcSEcCtD
Celecoxib—CYP2D6—digestive system—Crohn's disease	0.000139	0.00602	CbGeAlD
Celecoxib—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000139	0.00208	CcSEcCtD
Celecoxib—Bronchitis—Mesalazine—Crohn's disease	0.000138	0.00207	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000137	0.00205	CcSEcCtD
Celecoxib—Pancytopenia—Mesalazine—Crohn's disease	0.000136	0.00204	CcSEcCtD
Celecoxib—Dysuria—Mesalazine—Crohn's disease	0.000134	0.00201	CcSEcCtD
Celecoxib—Viral infection—Prednisone—Crohn's disease	0.000134	0.00201	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000133	0.002	CcSEcCtD
Celecoxib—Arthropathy—Prednisone—Crohn's disease	0.000133	0.00199	CcSEcCtD
Celecoxib—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000133	0.00199	CcSEcCtD
Celecoxib—Pollakiuria—Mesalazine—Crohn's disease	0.000133	0.00198	CcSEcCtD
Celecoxib—Agranulocytosis—Azathioprine—Crohn's disease	0.000131	0.00196	CcSEcCtD
Celecoxib—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000131	0.00196	CcSEcCtD
Celecoxib—Decreased appetite—Mercaptopurine—Crohn's disease	0.000131	0.00196	CcSEcCtD
Celecoxib—Weight increased—Mesalazine—Crohn's disease	0.000131	0.00196	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00013	0.00194	CcSEcCtD
Celecoxib—Pneumonia—Mesalazine—Crohn's disease	0.000129	0.00193	CcSEcCtD
Celecoxib—Infestation NOS—Mesalazine—Crohn's disease	0.000128	0.00192	CcSEcCtD
Celecoxib—Infestation—Mesalazine—Crohn's disease	0.000128	0.00192	CcSEcCtD
Celecoxib—Ulcer—Prednisone—Crohn's disease	0.000128	0.00192	CcSEcCtD
Celecoxib—Hypercholesterolaemia—Prednisone—Crohn's disease	0.000128	0.00192	CcSEcCtD
Celecoxib—Cataract—Prednisone—Crohn's disease	0.000127	0.0019	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000127	0.0019	CcSEcCtD
Celecoxib—Haemoglobin—Azathioprine—Crohn's disease	0.000127	0.0019	CcSEcCtD
Celecoxib—Haemorrhage—Azathioprine—Crohn's disease	0.000126	0.00189	CcSEcCtD
Celecoxib—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000126	0.00188	CcSEcCtD
Celecoxib—CA2—lymph node—Crohn's disease	0.000125	0.00542	CbGeAlD
Celecoxib—Jaundice—Mesalazine—Crohn's disease	0.000125	0.00187	CcSEcCtD
Celecoxib—Stomatitis—Mesalazine—Crohn's disease	0.000125	0.00187	CcSEcCtD
Celecoxib—Conjunctivitis—Mesalazine—Crohn's disease	0.000124	0.00186	CcSEcCtD
Celecoxib—Urinary tract infection—Mesalazine—Crohn's disease	0.000124	0.00186	CcSEcCtD
Celecoxib—Vasculitis—Prednisone—Crohn's disease	0.000124	0.00186	CcSEcCtD
Celecoxib—Haematuria—Mesalazine—Crohn's disease	0.000122	0.00183	CcSEcCtD
Celecoxib—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000121	0.00181	CcSEcCtD
Celecoxib—Epistaxis—Mesalazine—Crohn's disease	0.000121	0.00181	CcSEcCtD
Celecoxib—Sinusitis—Mesalazine—Crohn's disease	0.00012	0.0018	CcSEcCtD
Celecoxib—Agranulocytosis—Mesalazine—Crohn's disease	0.000119	0.00179	CcSEcCtD
Celecoxib—Erythema multiforme—Azathioprine—Crohn's disease	0.000119	0.00179	CcSEcCtD
Celecoxib—Body temperature increased—Mercaptopurine—Crohn's disease	0.000119	0.00178	CcSEcCtD
Celecoxib—Skin exfoliation—Prednisone—Crohn's disease	0.000116	0.00173	CcSEcCtD
Celecoxib—Haemoglobin—Mesalazine—Crohn's disease	0.000116	0.00173	CcSEcCtD
Celecoxib—Rhinitis—Mesalazine—Crohn's disease	0.000115	0.00172	CcSEcCtD
Celecoxib—Fluid retention—Prednisone—Crohn's disease	0.000115	0.00172	CcSEcCtD
Celecoxib—Haemorrhage—Mesalazine—Crohn's disease	0.000115	0.00172	CcSEcCtD
Celecoxib—Hepatitis—Mesalazine—Crohn's disease	0.000115	0.00172	CcSEcCtD
Celecoxib—Pharyngitis—Mesalazine—Crohn's disease	0.000114	0.00171	CcSEcCtD
Celecoxib—Immune system disorder—Azathioprine—Crohn's disease	0.000114	0.00171	CcSEcCtD
Celecoxib—Mediastinal disorder—Azathioprine—Crohn's disease	0.000114	0.0017	CcSEcCtD
Celecoxib—Neuropathy—Prednisone—Crohn's disease	0.000114	0.0017	CcSEcCtD
Celecoxib—Urinary tract disorder—Mesalazine—Crohn's disease	0.000114	0.0017	CcSEcCtD
Celecoxib—Oedema peripheral—Mesalazine—Crohn's disease	0.000113	0.00169	CcSEcCtD
Celecoxib—Connective tissue disorder—Mesalazine—Crohn's disease	0.000113	0.00169	CcSEcCtD
Celecoxib—Arrhythmia—Azathioprine—Crohn's disease	0.000113	0.00169	CcSEcCtD
Celecoxib—Urethral disorder—Mesalazine—Crohn's disease	0.000113	0.00169	CcSEcCtD
Celecoxib—Alopecia—Azathioprine—Crohn's disease	0.000112	0.00167	CcSEcCtD
Celecoxib—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000111	0.00166	CcSEcCtD
Celecoxib—Oesophagitis—Prednisone—Crohn's disease	0.000111	0.00166	CcSEcCtD
Celecoxib—Ecchymosis—Prednisone—Crohn's disease	0.000109	0.00164	CcSEcCtD
Celecoxib—Erythema multiforme—Mesalazine—Crohn's disease	0.000109	0.00163	CcSEcCtD
Celecoxib—Eye disorder—Mesalazine—Crohn's disease	0.000107	0.00161	CcSEcCtD
Celecoxib—Tinnitus—Mesalazine—Crohn's disease	0.000107	0.0016	CcSEcCtD
Celecoxib—Cardiac disorder—Mesalazine—Crohn's disease	0.000107	0.0016	CcSEcCtD
Celecoxib—Sepsis—Prednisone—Crohn's disease	0.000105	0.00157	CcSEcCtD
Celecoxib—Angiopathy—Mesalazine—Crohn's disease	0.000104	0.00156	CcSEcCtD
Celecoxib—Immune system disorder—Mesalazine—Crohn's disease	0.000104	0.00155	CcSEcCtD
Celecoxib—Mediastinal disorder—Mesalazine—Crohn's disease	0.000104	0.00155	CcSEcCtD
Celecoxib—Diarrhoea—Mercaptopurine—Crohn's disease	0.000103	0.00154	CcSEcCtD
Celecoxib—Alopecia—Mesalazine—Crohn's disease	0.000102	0.00152	CcSEcCtD
Celecoxib—Thrombophlebitis—Prednisone—Crohn's disease	0.000102	0.00152	CcSEcCtD
Celecoxib—Anaemia—Azathioprine—Crohn's disease	0.000102	0.00152	CcSEcCtD
Celecoxib—Diabetes mellitus—Prednisone—Crohn's disease	0.000101	0.00151	CcSEcCtD
Celecoxib—Mental disorder—Mesalazine—Crohn's disease	0.000101	0.00151	CcSEcCtD
Celecoxib—Flatulence—Mesalazine—Crohn's disease	9.86e-05	0.00148	CcSEcCtD
Celecoxib—Leukopenia—Azathioprine—Crohn's disease	9.83e-05	0.00147	CcSEcCtD
Celecoxib—Tension—Mesalazine—Crohn's disease	9.82e-05	0.00147	CcSEcCtD
Celecoxib—Dysgeusia—Mesalazine—Crohn's disease	9.8e-05	0.00147	CcSEcCtD
Celecoxib—Nervousness—Mesalazine—Crohn's disease	9.72e-05	0.00145	CcSEcCtD
Celecoxib—Cardiac failure congestive—Prednisone—Crohn's disease	9.69e-05	0.00145	CcSEcCtD
Celecoxib—Back pain—Mesalazine—Crohn's disease	9.68e-05	0.00145	CcSEcCtD
Celecoxib—Muscle spasms—Mesalazine—Crohn's disease	9.62e-05	0.00144	CcSEcCtD
Celecoxib—Vomiting—Mercaptopurine—Crohn's disease	9.57e-05	0.00143	CcSEcCtD
Celecoxib—Rash—Mercaptopurine—Crohn's disease	9.49e-05	0.00142	CcSEcCtD
Celecoxib—Dermatitis—Mercaptopurine—Crohn's disease	9.48e-05	0.00142	CcSEcCtD
Celecoxib—Vision blurred—Mesalazine—Crohn's disease	9.43e-05	0.00141	CcSEcCtD
Celecoxib—Increased appetite—Prednisone—Crohn's disease	9.36e-05	0.0014	CcSEcCtD
Celecoxib—Arthralgia—Azathioprine—Crohn's disease	9.35e-05	0.0014	CcSEcCtD
Celecoxib—Myalgia—Azathioprine—Crohn's disease	9.35e-05	0.0014	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	9.29e-05	0.00139	CcSEcCtD
Celecoxib—PTGS2—lymph node—Crohn's disease	9.26e-05	0.004	CbGeAlD
Celecoxib—Anaemia—Mesalazine—Crohn's disease	9.25e-05	0.00138	CcSEcCtD
Celecoxib—Angioedema—Mesalazine—Crohn's disease	9.14e-05	0.00137	CcSEcCtD
Celecoxib—Cardiac failure—Prednisone—Crohn's disease	9.01e-05	0.00135	CcSEcCtD
Celecoxib—Vertigo—Mesalazine—Crohn's disease	8.99e-05	0.00134	CcSEcCtD
Celecoxib—Syncope—Mesalazine—Crohn's disease	8.97e-05	0.00134	CcSEcCtD
Celecoxib—Leukopenia—Mesalazine—Crohn's disease	8.96e-05	0.00134	CcSEcCtD
Celecoxib—Nausea—Mercaptopurine—Crohn's disease	8.94e-05	0.00134	CcSEcCtD
Celecoxib—Infection—Azathioprine—Crohn's disease	8.91e-05	0.00133	CcSEcCtD
Celecoxib—Palpitations—Mesalazine—Crohn's disease	8.84e-05	0.00132	CcSEcCtD
Celecoxib—Loss of consciousness—Mesalazine—Crohn's disease	8.79e-05	0.00132	CcSEcCtD
Celecoxib—Osteoarthritis—Prednisone—Crohn's disease	8.79e-05	0.00132	CcSEcCtD
Celecoxib—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	8.79e-05	0.00132	CcSEcCtD
Celecoxib—Thrombocytopenia—Azathioprine—Crohn's disease	8.78e-05	0.00131	CcSEcCtD
Celecoxib—Cough—Mesalazine—Crohn's disease	8.73e-05	0.00131	CcSEcCtD
Celecoxib—Skin disorder—Azathioprine—Crohn's disease	8.71e-05	0.0013	CcSEcCtD
Celecoxib—Hypertension—Mesalazine—Crohn's disease	8.64e-05	0.00129	CcSEcCtD
Celecoxib—Myalgia—Mesalazine—Crohn's disease	8.52e-05	0.00127	CcSEcCtD
Celecoxib—Chest pain—Mesalazine—Crohn's disease	8.52e-05	0.00127	CcSEcCtD
Celecoxib—Arthralgia—Mesalazine—Crohn's disease	8.52e-05	0.00127	CcSEcCtD
Celecoxib—Anxiety—Mesalazine—Crohn's disease	8.49e-05	0.00127	CcSEcCtD
Celecoxib—Face oedema—Prednisone—Crohn's disease	8.49e-05	0.00127	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	8.46e-05	0.00127	CcSEcCtD
Celecoxib—Dry mouth—Mesalazine—Crohn's disease	8.33e-05	0.00125	CcSEcCtD
Celecoxib—Confusional state—Mesalazine—Crohn's disease	8.23e-05	0.00123	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Azathioprine—Crohn's disease	8.17e-05	0.00122	CcSEcCtD
Celecoxib—Oedema—Mesalazine—Crohn's disease	8.17e-05	0.00122	CcSEcCtD
Celecoxib—Anaphylactic shock—Mesalazine—Crohn's disease	8.17e-05	0.00122	CcSEcCtD
Celecoxib—Infection—Mesalazine—Crohn's disease	8.11e-05	0.00121	CcSEcCtD
Celecoxib—Dry skin—Prednisone—Crohn's disease	8.06e-05	0.00121	CcSEcCtD
Celecoxib—Shock—Mesalazine—Crohn's disease	8.03e-05	0.0012	CcSEcCtD
Celecoxib—Nervous system disorder—Mesalazine—Crohn's disease	8.01e-05	0.0012	CcSEcCtD
Celecoxib—Hypokalaemia—Prednisone—Crohn's disease	8e-05	0.0012	CcSEcCtD
Celecoxib—Thrombocytopenia—Mesalazine—Crohn's disease	8e-05	0.0012	CcSEcCtD
Celecoxib—Tachycardia—Mesalazine—Crohn's disease	7.97e-05	0.00119	CcSEcCtD
Celecoxib—Skin disorder—Mesalazine—Crohn's disease	7.93e-05	0.00119	CcSEcCtD
Celecoxib—Hyperhidrosis—Mesalazine—Crohn's disease	7.89e-05	0.00118	CcSEcCtD
Celecoxib—Anorexia—Mesalazine—Crohn's disease	7.78e-05	0.00116	CcSEcCtD
Celecoxib—Alanine aminotransferase increased—Prednisone—Crohn's disease	7.75e-05	0.00116	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Azathioprine—Crohn's disease	7.74e-05	0.00116	CcSEcCtD
Celecoxib—Pancreatitis—Prednisone—Crohn's disease	7.45e-05	0.00111	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Mesalazine—Crohn's disease	7.44e-05	0.00111	CcSEcCtD
Celecoxib—Sweating increased—Prednisone—Crohn's disease	7.4e-05	0.00111	CcSEcCtD
Celecoxib—Feeling abnormal—Azathioprine—Crohn's disease	7.39e-05	0.00111	CcSEcCtD
Celecoxib—Insomnia—Mesalazine—Crohn's disease	7.39e-05	0.00111	CcSEcCtD
Celecoxib—Paraesthesia—Mesalazine—Crohn's disease	7.33e-05	0.0011	CcSEcCtD
Celecoxib—Gastrointestinal pain—Azathioprine—Crohn's disease	7.33e-05	0.0011	CcSEcCtD
Celecoxib—Dyspnoea—Mesalazine—Crohn's disease	7.28e-05	0.00109	CcSEcCtD
Celecoxib—Somnolence—Mesalazine—Crohn's disease	7.26e-05	0.00109	CcSEcCtD
Celecoxib—Dyspepsia—Mesalazine—Crohn's disease	7.19e-05	0.00108	CcSEcCtD
Celecoxib—Decreased appetite—Mesalazine—Crohn's disease	7.1e-05	0.00106	CcSEcCtD
Celecoxib—Abdominal pain—Azathioprine—Crohn's disease	7.09e-05	0.00106	CcSEcCtD
Celecoxib—Body temperature increased—Azathioprine—Crohn's disease	7.09e-05	0.00106	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Mesalazine—Crohn's disease	7.05e-05	0.00105	CcSEcCtD
Celecoxib—Fatigue—Mesalazine—Crohn's disease	7.04e-05	0.00105	CcSEcCtD
Celecoxib—Constipation—Mesalazine—Crohn's disease	6.98e-05	0.00104	CcSEcCtD
Celecoxib—Weight increased—Prednisone—Crohn's disease	6.91e-05	0.00103	CcSEcCtD
Celecoxib—Hyperglycaemia—Prednisone—Crohn's disease	6.85e-05	0.00103	CcSEcCtD
Celecoxib—Feeling abnormal—Mesalazine—Crohn's disease	6.73e-05	0.00101	CcSEcCtD
Celecoxib—Acute coronary syndrome—Prednisone—Crohn's disease	6.68e-05	0.000999	CcSEcCtD
Celecoxib—Gastrointestinal pain—Mesalazine—Crohn's disease	6.68e-05	0.000999	CcSEcCtD
Celecoxib—Myocardial infarction—Prednisone—Crohn's disease	6.64e-05	0.000993	CcSEcCtD
Celecoxib—Neuropathy peripheral—Prednisone—Crohn's disease	6.64e-05	0.000993	CcSEcCtD
Celecoxib—Hypersensitivity—Azathioprine—Crohn's disease	6.61e-05	0.000988	CcSEcCtD
Celecoxib—Urticaria—Mesalazine—Crohn's disease	6.49e-05	0.000971	CcSEcCtD
Celecoxib—Abdominal pain—Mesalazine—Crohn's disease	6.46e-05	0.000966	CcSEcCtD
Celecoxib—Body temperature increased—Mesalazine—Crohn's disease	6.46e-05	0.000966	CcSEcCtD
Celecoxib—Diarrhoea—Azathioprine—Crohn's disease	6.13e-05	0.000918	CcSEcCtD
Celecoxib—Haemoglobin—Prednisone—Crohn's disease	6.11e-05	0.000914	CcSEcCtD
Celecoxib—Haemorrhage—Prednisone—Crohn's disease	6.08e-05	0.00091	CcSEcCtD
Celecoxib—Hallucination—Prednisone—Crohn's disease	6.05e-05	0.000905	CcSEcCtD
Celecoxib—Hypersensitivity—Mesalazine—Crohn's disease	6.02e-05	0.0009	CcSEcCtD
Celecoxib—Connective tissue disorder—Prednisone—Crohn's disease	5.98e-05	0.000894	CcSEcCtD
Celecoxib—Dizziness—Azathioprine—Crohn's disease	5.93e-05	0.000887	CcSEcCtD
Celecoxib—Asthenia—Mesalazine—Crohn's disease	5.86e-05	0.000877	CcSEcCtD
Celecoxib—Pruritus—Mesalazine—Crohn's disease	5.78e-05	0.000864	CcSEcCtD
Celecoxib—Vomiting—Azathioprine—Crohn's disease	5.7e-05	0.000853	CcSEcCtD
Celecoxib—Eye disorder—Prednisone—Crohn's disease	5.68e-05	0.00085	CcSEcCtD
Celecoxib—Rash—Azathioprine—Crohn's disease	5.65e-05	0.000846	CcSEcCtD
Celecoxib—Dermatitis—Azathioprine—Crohn's disease	5.65e-05	0.000845	CcSEcCtD
Celecoxib—Flushing—Prednisone—Crohn's disease	5.64e-05	0.000844	CcSEcCtD
Celecoxib—Headache—Azathioprine—Crohn's disease	5.62e-05	0.00084	CcSEcCtD
Celecoxib—Diarrhoea—Mesalazine—Crohn's disease	5.59e-05	0.000836	CcSEcCtD
Celecoxib—Angiopathy—Prednisone—Crohn's disease	5.52e-05	0.000825	CcSEcCtD
Celecoxib—Immune system disorder—Prednisone—Crohn's disease	5.49e-05	0.000822	CcSEcCtD
Celecoxib—Arrhythmia—Prednisone—Crohn's disease	5.43e-05	0.000813	CcSEcCtD
Celecoxib—Dizziness—Mesalazine—Crohn's disease	5.4e-05	0.000808	CcSEcCtD
Celecoxib—Alopecia—Prednisone—Crohn's disease	5.37e-05	0.000804	CcSEcCtD
Celecoxib—Mental disorder—Prednisone—Crohn's disease	5.33e-05	0.000797	CcSEcCtD
Celecoxib—Nausea—Azathioprine—Crohn's disease	5.33e-05	0.000797	CcSEcCtD
Celecoxib—Vomiting—Mesalazine—Crohn's disease	5.19e-05	0.000777	CcSEcCtD
Celecoxib—Rash—Mesalazine—Crohn's disease	5.15e-05	0.00077	CcSEcCtD
Celecoxib—Dermatitis—Mesalazine—Crohn's disease	5.14e-05	0.00077	CcSEcCtD
Celecoxib—Headache—Mesalazine—Crohn's disease	5.12e-05	0.000765	CcSEcCtD
Celecoxib—Vision blurred—Prednisone—Crohn's disease	4.99e-05	0.000746	CcSEcCtD
Celecoxib—Anaemia—Prednisone—Crohn's disease	4.89e-05	0.000732	CcSEcCtD
Celecoxib—Nausea—Mesalazine—Crohn's disease	4.85e-05	0.000726	CcSEcCtD
Celecoxib—Angioedema—Prednisone—Crohn's disease	4.84e-05	0.000724	CcSEcCtD
Celecoxib—Vertigo—Prednisone—Crohn's disease	4.76e-05	0.000712	CcSEcCtD
Celecoxib—Syncope—Prednisone—Crohn's disease	4.75e-05	0.00071	CcSEcCtD
Celecoxib—Loss of consciousness—Prednisone—Crohn's disease	4.65e-05	0.000696	CcSEcCtD
Celecoxib—Hypertension—Prednisone—Crohn's disease	4.57e-05	0.000684	CcSEcCtD
Celecoxib—Arthralgia—Prednisone—Crohn's disease	4.51e-05	0.000674	CcSEcCtD
Celecoxib—Myalgia—Prednisone—Crohn's disease	4.51e-05	0.000674	CcSEcCtD
Celecoxib—Anxiety—Prednisone—Crohn's disease	4.49e-05	0.000672	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	4.48e-05	0.00067	CcSEcCtD
Celecoxib—Oedema—Prednisone—Crohn's disease	4.32e-05	0.000646	CcSEcCtD
Celecoxib—Anaphylactic shock—Prednisone—Crohn's disease	4.32e-05	0.000646	CcSEcCtD
Celecoxib—Infection—Prednisone—Crohn's disease	4.29e-05	0.000642	CcSEcCtD
Celecoxib—Shock—Prednisone—Crohn's disease	4.25e-05	0.000636	CcSEcCtD
Celecoxib—Nervous system disorder—Prednisone—Crohn's disease	4.24e-05	0.000634	CcSEcCtD
Celecoxib—Tachycardia—Prednisone—Crohn's disease	4.22e-05	0.000631	CcSEcCtD
Celecoxib—Skin disorder—Prednisone—Crohn's disease	4.2e-05	0.000628	CcSEcCtD
Celecoxib—Hyperhidrosis—Prednisone—Crohn's disease	4.18e-05	0.000625	CcSEcCtD
Celecoxib—Anorexia—Prednisone—Crohn's disease	4.12e-05	0.000616	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Prednisone—Crohn's disease	3.94e-05	0.000589	CcSEcCtD
Celecoxib—Insomnia—Prednisone—Crohn's disease	3.91e-05	0.000585	CcSEcCtD
Celecoxib—Paraesthesia—Prednisone—Crohn's disease	3.88e-05	0.00058	CcSEcCtD
Celecoxib—Dyspepsia—Prednisone—Crohn's disease	3.8e-05	0.000569	CcSEcCtD
Celecoxib—Decreased appetite—Prednisone—Crohn's disease	3.76e-05	0.000562	CcSEcCtD
Celecoxib—Fatigue—Prednisone—Crohn's disease	3.72e-05	0.000557	CcSEcCtD
Celecoxib—Constipation—Prednisone—Crohn's disease	3.69e-05	0.000553	CcSEcCtD
Celecoxib—Feeling abnormal—Prednisone—Crohn's disease	3.56e-05	0.000533	CcSEcCtD
Celecoxib—Gastrointestinal pain—Prednisone—Crohn's disease	3.53e-05	0.000529	CcSEcCtD
Celecoxib—Urticaria—Prednisone—Crohn's disease	3.43e-05	0.000514	CcSEcCtD
Celecoxib—Body temperature increased—Prednisone—Crohn's disease	3.42e-05	0.000511	CcSEcCtD
Celecoxib—Abdominal pain—Prednisone—Crohn's disease	3.42e-05	0.000511	CcSEcCtD
Celecoxib—Hypersensitivity—Prednisone—Crohn's disease	3.18e-05	0.000476	CcSEcCtD
Celecoxib—Asthenia—Prednisone—Crohn's disease	3.1e-05	0.000464	CcSEcCtD
Celecoxib—Pruritus—Prednisone—Crohn's disease	3.06e-05	0.000457	CcSEcCtD
Celecoxib—Diarrhoea—Prednisone—Crohn's disease	2.96e-05	0.000442	CcSEcCtD
Celecoxib—Dizziness—Prednisone—Crohn's disease	2.86e-05	0.000427	CcSEcCtD
Celecoxib—Vomiting—Prednisone—Crohn's disease	2.75e-05	0.000411	CcSEcCtD
Celecoxib—Rash—Prednisone—Crohn's disease	2.72e-05	0.000408	CcSEcCtD
Celecoxib—Dermatitis—Prednisone—Crohn's disease	2.72e-05	0.000407	CcSEcCtD
Celecoxib—Headache—Prednisone—Crohn's disease	2.71e-05	0.000405	CcSEcCtD
Celecoxib—Nausea—Prednisone—Crohn's disease	2.57e-05	0.000384	CcSEcCtD
Celecoxib—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	1.76e-05	0.000377	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—STAT3—Crohn's disease	1.76e-05	0.000376	CbGpPWpGaD
Celecoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—IL6—Crohn's disease	1.76e-05	0.000376	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NOD2—Crohn's disease	1.75e-05	0.000374	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—DNMT3A—Crohn's disease	1.73e-05	0.000371	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—PTGS2—Crohn's disease	1.73e-05	0.00037	CbGpPWpGaD
Celecoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—IL6—Crohn's disease	1.73e-05	0.00037	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—RIPK2—Crohn's disease	1.72e-05	0.000368	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	1.7e-05	0.000364	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—JAK2—Crohn's disease	1.69e-05	0.000361	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TAGAP—Crohn's disease	1.68e-05	0.000359	CbGpPWpGaD
Celecoxib—MAPK14—MyD88-independent cascade—IL6—Crohn's disease	1.66e-05	0.000355	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—SOCS1—Crohn's disease	1.64e-05	0.000352	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	1.64e-05	0.000351	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—RASGRP1—Crohn's disease	1.62e-05	0.000347	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCR6—Crohn's disease	1.62e-05	0.000347	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	1.62e-05	0.000347	CbGpPWpGaD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL6—Crohn's disease	1.62e-05	0.000346	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL1B—Crohn's disease	1.61e-05	0.000344	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—F5—Crohn's disease	1.6e-05	0.000344	CbGpPWpGaD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—STAT3—Crohn's disease	1.6e-05	0.000342	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—TYK2—Crohn's disease	1.59e-05	0.000341	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—TAB1—Crohn's disease	1.59e-05	0.000339	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—IL2RA—Crohn's disease	1.58e-05	0.000339	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—Crohn's disease	1.58e-05	0.000338	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	1.57e-05	0.000336	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—Crohn's disease	1.56e-05	0.000335	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—NOD2—Crohn's disease	1.56e-05	0.000333	CbGpPWpGaD
Celecoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—Crohn's disease	1.56e-05	0.000333	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.54e-05	0.00033	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—JAK2—Crohn's disease	1.52e-05	0.000325	CbGpPWpGaD
Celecoxib—MAPK14—Activated TLR4 signalling—IL6—Crohn's disease	1.49e-05	0.000319	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IL2RA—Crohn's disease	1.49e-05	0.000319	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL18—Crohn's disease	1.48e-05	0.000317	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by VEGF—IL6—Crohn's disease	1.47e-05	0.000315	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—SOCS1—Crohn's disease	1.47e-05	0.000314	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—TNF—Crohn's disease	1.47e-05	0.000314	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RSPO3—Crohn's disease	1.46e-05	0.000314	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RBX1—Crohn's disease	1.46e-05	0.000313	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—IL6—Crohn's disease	1.46e-05	0.000312	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—TYK2—Crohn's disease	1.45e-05	0.00031	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.44e-05	0.000309	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	1.44e-05	0.000309	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL2RA—Crohn's disease	1.44e-05	0.000308	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—CD4—Crohn's disease	1.44e-05	0.000308	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—SMAD3—Crohn's disease	1.43e-05	0.000307	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NOD1—Crohn's disease	1.43e-05	0.000307	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—STAT3—Crohn's disease	1.43e-05	0.000307	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PTGER4—Crohn's disease	1.42e-05	0.000305	CbGpPWpGaD
Celecoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—Crohn's disease	1.4e-05	0.0003	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SEL1L—Crohn's disease	1.39e-05	0.000297	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—JAK2—Crohn's disease	1.38e-05	0.000296	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—CD4—Crohn's disease	1.38e-05	0.000296	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by NGF—IL6—Crohn's disease	1.36e-05	0.000292	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—CXCL8—Crohn's disease	1.35e-05	0.000288	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—TNF—Crohn's disease	1.34e-05	0.000288	CbGpPWpGaD
Celecoxib—PTGS2—Disease—RSPO3—Crohn's disease	1.34e-05	0.000286	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—GCKR—Crohn's disease	1.32e-05	0.000284	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—STAT3—Crohn's disease	1.32e-05	0.000283	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL2RA—Crohn's disease	1.32e-05	0.000282	CbGpPWpGaD
Celecoxib—PDPK1—Disease—SMAD3—Crohn's disease	1.31e-05	0.000281	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL2RA—Crohn's disease	1.31e-05	0.00028	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL2RA—Crohn's disease	1.3e-05	0.000279	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CCR6—Crohn's disease	1.3e-05	0.000279	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—UBE2D1—Crohn's disease	1.28e-05	0.000275	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PLA2G4F—Crohn's disease	1.28e-05	0.000274	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCR9—Crohn's disease	1.27e-05	0.000272	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SEL1L—Crohn's disease	1.27e-05	0.000271	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—Crohn's disease	1.26e-05	0.00027	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.26e-05	0.00027	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—IL6—Crohn's disease	1.25e-05	0.000268	CbGpPWpGaD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—IL6—Crohn's disease	1.25e-05	0.000267	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RIPK2—Crohn's disease	1.24e-05	0.000267	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CRP—Crohn's disease	1.24e-05	0.000266	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL3—Crohn's disease	1.21e-05	0.00026	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.21e-05	0.00026	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PTPN2—Crohn's disease	1.19e-05	0.000255	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—TLR4—Crohn's disease	1.19e-05	0.000255	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—IL6—Crohn's disease	1.18e-05	0.000254	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.18e-05	0.000253	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GPR65—Crohn's disease	1.18e-05	0.000253	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—RBX1—Crohn's disease	1.18e-05	0.000252	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RASGRP1—Crohn's disease	1.17e-05	0.000251	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	1.17e-05	0.000251	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—HSPA1B—Crohn's disease	1.17e-05	0.000251	CbGpPWpGaD
Celecoxib—CA14—Metabolism—ALB—Crohn's disease	1.17e-05	0.00025	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—TNF—Crohn's disease	1.17e-05	0.00025	CbGpPWpGaD
Celecoxib—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	1.16e-05	0.000249	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—ICAM1—Crohn's disease	1.14e-05	0.000244	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	1.14e-05	0.000244	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—ALB—Crohn's disease	1.14e-05	0.000243	CbGpPWpGaD
Celecoxib—CA6—Metabolism—ALB—Crohn's disease	1.14e-05	0.000243	CbGpPWpGaD
Celecoxib—PTGS2—Disease—LTF—Crohn's disease	1.14e-05	0.000243	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CRP—Crohn's disease	1.11e-05	0.000237	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTMR3—Crohn's disease	1.09e-05	0.000233	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—STAT3—Crohn's disease	1.08e-05	0.000232	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—ALB—Crohn's disease	1.08e-05	0.00023	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—JAK2—Crohn's disease	1.07e-05	0.000228	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SOCS1—Crohn's disease	1.06e-05	0.000228	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—TLR4—Crohn's disease	1.06e-05	0.000227	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ALB—Crohn's disease	1.06e-05	0.000227	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PLA2G4F—Crohn's disease	1.04e-05	0.000222	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—UBE2D1—Crohn's disease	1.03e-05	0.000221	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—UBE2D1—Crohn's disease	1.03e-05	0.00022	CbGpPWpGaD
Celecoxib—CA14—Metabolism—PTGS2—Crohn's disease	1.02e-05	0.000218	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—STAT3—Crohn's disease	1.01e-05	0.000217	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—TYK2—Crohn's disease	1.01e-05	0.000217	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—JAK2—Crohn's disease	1e-05	0.000214	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—RIPK2—Crohn's disease	1e-05	0.000214	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ITGA4—Crohn's disease	1e-05	0.000214	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—IL6—Crohn's disease	1e-05	0.000214	CbGpPWpGaD
Celecoxib—CA6—Metabolism—PTGS2—Crohn's disease	9.94e-06	0.000213	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—PTGS2—Crohn's disease	9.94e-06	0.000213	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—ITGA4—Crohn's disease	9.86e-06	0.000211	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ALB—Crohn's disease	9.83e-06	0.00021	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL3—Crohn's disease	9.76e-06	0.000209	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CXCL8—Crohn's disease	9.72e-06	0.000208	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—JAK2—Crohn's disease	9.67e-06	0.000207	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL3—Crohn's disease	9.62e-06	0.000206	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—RASGRP1—Crohn's disease	9.44e-06	0.000202	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—ALB—Crohn's disease	9.42e-06	0.000202	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL6—Crohn's disease	9.41e-06	0.000201	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD79A—Crohn's disease	9.41e-06	0.000201	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TYK2—Crohn's disease	9.36e-06	0.0002	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ALB—Crohn's disease	9.32e-06	0.0002	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—RASGRP1—Crohn's disease	9.3e-06	0.000199	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—PTGS2—Crohn's disease	9.28e-06	0.000199	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—TYK2—Crohn's disease	9.27e-06	0.000198	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TAB1—Crohn's disease	9.23e-06	0.000198	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—Crohn's disease	9.22e-06	0.000197	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	9.19e-06	0.000197	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SMAD3—Crohn's disease	9.18e-06	0.000197	CbGpPWpGaD
Celecoxib—PTGS2—Disease—GCKR—Crohn's disease	9.16e-06	0.000196	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NOD2—Crohn's disease	9.07e-06	0.000194	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—JAK2—Crohn's disease	8.93e-06	0.000191	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—JAK2—Crohn's disease	8.84e-06	0.000189	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CXCL8—Crohn's disease	8.83e-06	0.000189	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTMR3—Crohn's disease	8.81e-06	0.000189	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	8.78e-06	0.000188	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—JAK2—Crohn's disease	8.76e-06	0.000188	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IFNG—Crohn's disease	8.68e-06	0.000186	CbGpPWpGaD
Celecoxib—CA12—Metabolism—PTGS2—Crohn's disease	8.6e-06	0.000184	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TYK2—Crohn's disease	8.55e-06	0.000183	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	8.55e-06	0.000183	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—SOCS1—Crohn's disease	8.55e-06	0.000183	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2RA—Crohn's disease	8.5e-06	0.000182	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—FADS1—Crohn's disease	8.48e-06	0.000182	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	8.48e-06	0.000182	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCR6—Crohn's disease	8.41e-06	0.00018	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD4—Crohn's disease	8.38e-06	0.000179	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—TYK2—Crohn's disease	8.27e-06	0.000177	CbGpPWpGaD
Celecoxib—PDPK1—Disease—JAK2—Crohn's disease	8.16e-06	0.000175	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC11A1—Crohn's disease	8.09e-06	0.000173	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GPX4—Crohn's disease	7.94e-06	0.00017	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—JAK2—Crohn's disease	7.89e-06	0.000169	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ALB—Crohn's disease	7.84e-06	0.000168	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IL6—Crohn's disease	7.78e-06	0.000167	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	7.75e-06	0.000166	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL1B—Crohn's disease	7.74e-06	0.000166	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CD4—Crohn's disease	7.74e-06	0.000166	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL18—Crohn's disease	7.7e-06	0.000165	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTGS2—Crohn's disease	7.68e-06	0.000164	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GCKR—Crohn's disease	7.67e-06	0.000164	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RBX1—Crohn's disease	7.61e-06	0.000163	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—IL6—Crohn's disease	7.56e-06	0.000162	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ALB—Crohn's disease	7.51e-06	0.000161	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CD4—Crohn's disease	7.48e-06	0.00016	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTGER4—Crohn's disease	7.4e-06	0.000159	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—SMAD3—Crohn's disease	7.34e-06	0.000157	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTMR3—Crohn's disease	7.27e-06	0.000156	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTMR3—Crohn's disease	7.21e-06	0.000154	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—IL6—Crohn's disease	7.09e-06	0.000152	CbGpPWpGaD
Celecoxib—PTGS2—Disease—RBX1—Crohn's disease	6.94e-06	0.000149	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HSPA1B—Crohn's disease	6.94e-06	0.000149	CbGpPWpGaD
Celecoxib—ALB—Metabolism—FADS1—Crohn's disease	6.86e-06	0.000147	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—Crohn's disease	6.85e-06	0.000147	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2RA—Crohn's disease	6.83e-06	0.000146	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2RA—Crohn's disease	6.74e-06	0.000144	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—UBE2D1—Crohn's disease	6.67e-06	0.000143	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—Crohn's disease	6.57e-06	0.000141	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—STAT3—Crohn's disease	6.55e-06	0.00014	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—STAT3—Crohn's disease	6.49e-06	0.000139	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RIPK2—Crohn's disease	6.47e-06	0.000139	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CRP—Crohn's disease	6.45e-06	0.000138	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GPX4—Crohn's disease	6.42e-06	0.000138	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ALB—Crohn's disease	6.33e-06	0.000136	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL3—Crohn's disease	6.31e-06	0.000135	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GCKR—Crohn's disease	6.2e-06	0.000133	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TLR4—Crohn's disease	6.18e-06	0.000132	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RASGRP1—Crohn's disease	6.1e-06	0.000131	CbGpPWpGaD
Celecoxib—PTGS2—Disease—UBE2D1—Crohn's disease	6.08e-06	0.00013	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TYK2—Crohn's disease	5.99e-06	0.000128	CbGpPWpGaD
Celecoxib—PDPK1—Disease—STAT3—Crohn's disease	5.99e-06	0.000128	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ICAM1—Crohn's disease	5.93e-06	0.000127	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—JAK2—Crohn's disease	5.71e-06	0.000122	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—Crohn's disease	5.67e-06	0.000121	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—FADS1—Crohn's disease	5.66e-06	0.000121	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—FADS1—Crohn's disease	5.62e-06	0.00012	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	5.59e-06	0.00012	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—Crohn's disease	5.54e-06	0.000119	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SOCS1—Crohn's disease	5.53e-06	0.000118	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.48e-06	0.000117	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GPX4—Crohn's disease	5.3e-06	0.000114	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GPX4—Crohn's disease	5.26e-06	0.000113	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCL8—Crohn's disease	5.22e-06	0.000112	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GCKR—Crohn's disease	5.12e-06	0.00011	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GCKR—Crohn's disease	5.08e-06	0.000109	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—Crohn's disease	4.96e-06	0.000106	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TYK2—Crohn's disease	4.81e-06	0.000103	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SMAD3—Crohn's disease	4.77e-06	0.000102	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTMR3—Crohn's disease	4.75e-06	0.000102	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—JAK2—Crohn's disease	4.59e-06	9.84e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—Crohn's disease	4.58e-06	9.8e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—Crohn's disease	4.53e-06	9.7e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—JAK2—Crohn's disease	4.53e-06	9.7e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNG—Crohn's disease	4.51e-06	9.66e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2RA—Crohn's disease	4.42e-06	9.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD4—Crohn's disease	4.35e-06	9.32e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SMAD3—Crohn's disease	4.35e-06	9.32e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—STAT3—Crohn's disease	4.19e-06	8.98e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—Crohn's disease	4.18e-06	8.96e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—Crohn's disease	4.04e-06	8.66e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—Crohn's disease	4.02e-06	8.61e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.88e-06	8.31e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—FADS1—Crohn's disease	3.7e-06	7.93e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.63e-06	7.77e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX4—Crohn's disease	3.47e-06	7.43e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—STAT3—Crohn's disease	3.37e-06	7.22e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GCKR—Crohn's disease	3.35e-06	7.17e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.17e-06	6.8e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TYK2—Crohn's disease	3.11e-06	6.67e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—JAK2—Crohn's disease	2.97e-06	6.36e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—Crohn's disease	2.93e-06	6.27e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TYK2—Crohn's disease	2.84e-06	6.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL8—Crohn's disease	2.71e-06	5.8e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—JAK2—Crohn's disease	2.71e-06	5.8e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD4—Crohn's disease	2.57e-06	5.5e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—Crohn's disease	2.44e-06	5.23e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—Crohn's disease	2.35e-06	5.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STAT3—Crohn's disease	2.18e-06	4.67e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—STAT3—Crohn's disease	1.99e-06	4.26e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—Crohn's disease	1.73e-06	3.7e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—Crohn's disease	1.63e-06	3.49e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—Crohn's disease	1.62e-06	3.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—Crohn's disease	1.52e-06	3.26e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.43e-06	3.05e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.41e-06	3.03e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—Crohn's disease	1.39e-06	2.97e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—Crohn's disease	1.07e-06	2.28e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—Crohn's disease	9.32e-07	2e-05	CbGpPWpGaD
